Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • Activate Immunotherapy completes venture financing

    Activate Immunotherapy, San Diego, Calif. Business: Cancer Date completed: 2016-08-15 Type: Venture financing Raised: Not disclosed Note: The amount raised is not disclosed.

    Published on 8/22/2016
  • AdAlta completes IPO

    AdAlta Ltd. (ASX:1AD), Bundoora, Australia Business: Antibodies, Pulmonary Date completed: 2016-08-12 Type: IPO Raised: A$10 million ($7.7 million) Shares: 40 million Price: A$0.25 Shares after offering: 100 million …

    Published on 8/22/2016
  • Advaxis completes direct public offering

    Advaxis Inc. (NASDAQ:ADXS), Princeton, N.J. Business: Cancer Date completed: 2016-08-16 Type: Direct public offering Raised: $30.3 million Shares: 2.2 million Price: $13.50 Shares after offering: 39.6 million Placement …

    Published on 8/22/2016
  • Arno completes private placement of units

    Arno Therapeutics Inc. (OTCQB:ARNI), Flemington, N.J. Business: Cancer, Infectious Date completed: 2016-08-16 Type: Private placement of units Raised: $2.8 million Units: 7.9 million Price: $0.35 (unit) Shares after …

    Published on 8/22/2016
  • Atomo Diagnostics completes venture financing

    Atomo Diagnostics, Leichhardt, Australia Business: Diagnostic Date completed: 2016-08-11 Type: Venture financing Raised: A$4.5 million ($3.5 million) Investors: Global Health Investment Fund; private investor

    Published on 8/22/2016
  • Avelas Biosciences completes venture financing

    Avelas Biosciences Inc., La Jolla, Calif. Business: Cancer, Diagnostic Date completed: 2016-08-18 Type: Venture financing Raised: $20 million Investors: Pharmstandard International S.A.; Ervington Investments; …

    Published on 8/22/2016
  • Eiger completes follow-on

    Eiger BioPharmaceuticals Inc. (NASDAQ:EIGR), Palo Alto, Calif. Business: Infectious, Endocrine/Metabolic, Cardiovascular Date completed: 2016-08-18 Type: Follow-on Raised: $20 million Shares: 1.3 million Price: $16 …

    Published on 8/22/2016
  • Genmab completes warrant exercise

    Genmab A/S (CSE:GEN), Copenhagen, Denmark Business: Antibodies, Cancer, Autoimmune Date completed: 2016-08-17 Type: Warrant exercise Raised: DKK83.9 million ($12.6 million) Shares: 347,825 Shares after offering: 60.2 …

    Published on 8/22/2016
  • Lattice Biologics completes private placement of units

    Lattice Biologics Ltd. (TSX-V:LBL), Scottsdale, Ariz. Business: Gene/Cell therapy, Diagnostic Date completed: 2016-08-08 Type: Private placement of units Raised: C$320,545 ($247,781) Units: 1.6 million Price: C$0.20 (…

    Published on 8/22/2016
  • MabVax Therapeutics completes follow-on

    MabVax Therapeutics Holdings Inc. (NASDAQ:MBVX), San Diego, Calif. Business: Cancer Date completed: 2016-08-17 Type: Follow-on Raised: $8.6 million Shares: 1.1 million Price: $4.81 Shares after offering: 5.4 million …

    Published on 8/22/2016
  • MonoSol Rx completes venture financing

    MonoSol Rx LLC, Warren, N.J. Business: Drug delivery, Neurology, Endocrine/Metabolic Date completed: 2016-08-17 Type: Venture financing Raised: $50 million Investor: Perceptive Advisors Note: MonoSol said it will use a …

    Published on 8/22/2016
  • Nutrinia completes venture financing

    Nutrinia Ltd., Ramat Gan, Israel Business: Gastrointestinal Date completed: 2016-08-18 Type: Venture financing Raised: $30 million Investors: TPG Biotech; H.I.G. Capital LLC; WuXi Healthcare Ventures; OrbiMed Advisors; …

    Published on 8/22/2016
  • Nymox completes private placement

    Nymox Pharmaceutical Corp. (NASDAQ:NYMX), Saint-Laurent, Quebec Business: Genitourinary, Neurology, Diagnostic Date completed: 2016-08-17 Type: Private placement Raised: $2.2 million Shares: 965,649 Shares after …

    Published on 8/22/2016
  • Oculis completes venture financing

    Oculis ehf, Reykjavik, Iceland Business: Drug delivery, Ophthalmic Date completed: 2016-08-16 Type: Venture financing Raised: Not disclosed Investors: Brunnur Ventures; Silfurberg Note: The amount raised is not …

    Published on 8/22/2016
  • OncoMed completes follow-on

    OncoMed Pharmaceuticals Inc. (NASDAQ:OMED), Redwood City, Calif. Business: Cancer Date completed: 2016-08-18 Type: Follow-on Raised: $55 million Shares: 5.5 million Price: $10 Shares after offering: 36.2 million …

    Published on 8/22/2016
  • ProteoMediX completes venture financing

    ProteoMediX AG, Zurich, Switzerland Business: Diagnostic Date completed: 2016-08-16 Type: Venture financing Raised: CHF5 million ($5.1 million) Investors: Altos Venture; Zuercher Kantonalbank; existing investors; …

    Published on 8/22/2016
  • Recro completes follow-on

    Recro Pharma Inc. (NASDAQ:REPH), Malvern, Pa. Business: Neurology Date completed: 2016-08-16 Type: Follow-on Raised: $14.9 million Shares: 2 million Price: $7.50 Shares after offering: 11.9 million Underwriters: Piper …

    Published on 8/22/2016
  • Revive Therapeutics completes private placement of units

    Revive Therapeutics Ltd. (TSX-V:RVV; OTCQB:RVVTF), Vaughan, Ontario Business: Neurology, Autoimmune, Endocrine/Metabolic Date completed: 2016-08-18 Type: Private placement of units Raised: C$1.5 million ($1.2 million) …

    Published on 8/22/2016
  • Sensorion completes private placement of convertible notes and warrants

    Sensorion S.A. (Euronext:ALSEN), Clapiers, France Business: Other Date completed: 2016-08-17 Type: Private placement of convertible notes and warrants Raised: EUR3 million ($3.4 million) Shares: 300 Shares outstanding …

    Published on 8/22/2016
  • Tioma completes venture financing

    Tioma Therapeutics Inc., Brisbane, Calif. Business: Cancer Date completed: 2016-08-16 Type: Venture financing Raised: $86 million Investors: RiverVest Venture Partners; Novo Ventures; Roche Venture Fund; SR One

    Published on 8/22/2016
  • Alimera Sciences financial update

    Alimera Sciences Inc. (NASDAQ:ALIM), Alpharetta, Ga. Business: Ophthalmic Date announced: 2016-08-16 Note: Alimera raised $1.3 million through the sale of 900,000 shares at $1.40 to cover the overallotment from its Aug.…

    Published on 8/22/2016
  • Amarin financial update

    Amarin Corp. plc (NASDAQ:AMRN), Dublin, Ireland Business: Cardiovascular, Endocrine/Metabolic Date announced: 2016-08-15 Note: Amarin raised $9 million through the sale of 3.2 million ADSs at $2.85 to cover the …

    Published on 8/22/2016
  • Cambridge Innovation Capital plc financial update

    Cambridge Innovation Capital plc, Cambridge, U.K. Business: Finance Date announced: 2016-08-19 Note: Cambridge Innovation Capital raised L75 million ($97 million). The firm, which invests in technology and healthcare …

    Published on 8/22/2016
  • Genesys Capital financial update

    Genesys Capital, Toronto, Ontario Business: Finance Date announced: 2016-08-16 Note: Knight Therapeutics Inc. (TSX-V:GUD, Westmount, Quebec) invested C$1 million ($773,000) in Genesys Ventures III L.P., a Canadian-based…

    Published on 8/22/2016
  • Xtant Medical financial update

    Xtant Medical Holdings Inc. (NYSE-M:XTNT), Belgrade, Mont. Business: Supply/Service, Musculoskeletal Date announced: 2016-08-16 Note: Xtant amended its revolving line of credit with Silicon Valley Bank to increase the …

    Published on 8/22/2016

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993